Children’s Sleepwear Regulations (SOR/2016-169)

Interpretation

Marginal note:Definitions

1 The following definitions apply in these Regulations.

CGSB

CGSB means the Canadian General Standards Board. (ONGC)

char length

char length means the maximum extent of the damaged length of a material that has been subjected to the tests set out in these Regulations. (longueur carbonisée)

loose-fitting sleepwear

loose-fitting sleepwear means children’s nightgowns, nightshirts, dressing gowns, bathrobes, housecoats, robes, pyjamas and baby-doll pyjamas in sizes up to and including 14X, other than sleepwear designed for infants weighing up to 7 kg, sleepwear designed for use in a hospital, polo pyjamas and sleepers. (vêtement de nuit ample)

OECD

OECD means the Organisation for Economic Cooperation and Development. (OCDE)

tight-fitting sleepwear

tight-fitting sleepwear means any children’s sleepwear in sizes up to and including 14X other than loose-fitting sleepwear. It includes

• (a) sleepwear designed for infants weighing up to 7 kg;

• (b) sleepwear designed for use in a hospital;

• (c) polo pyjamas; and

• (d) sleepers. (vêtement de nuit ajusté)

Specifications

Marginal note:Tight-fitting sleepwear

2 Tight-fitting sleepwear when tested in accordance with the CGSB standard CAN/CGSB-4.2 No. 27.5, entitled Textile Test Methods: Flame Resistance — 45° Angle Test — One-Second Flame Impingement, as amended from time to time, must have a time of flame spread of more than seven seconds.

Marginal note:Loose-fitting sleepwear — flame resistance test

• 3 (1) Loose-fitting sleepwear, when tested in accordance with Schedule 1, must have

  • (a) an average char length for five specimens that does not exceed 178 mm; and

  • (b) not more than one specimen with a char length equal to the full length of the specimen.

• Marginal note:Loose-fitting sleepwear — other tests

  (2) Loose-fitting sleepwear that is treated with a flame retardant, any component that is extracted or broken down from such treated sleepwear and any flame retardant that is used to treat the sleepwear must not cause any of the following consequences:

  • (a) acute lethality as a result of oral exposure to a dose of 500 mg/kg body weight or less or as a result of dermal exposure to a dose of 1000 mg/kg body weight or less when tested for acute oral toxicity or acute dermal toxicity in accordance with section 1 or 2, as the case may be, of Schedule 2;

  • (b) an effect graded at a mean greater than 1 for erythema formation or for edema formation measured at any specified time when tested for dermal irritation in accordance with section 3 of Schedule 2;

  • (c) when tested for dermal sensitisation in accordance with section 4 of Schedule 2, a response in greater than 15% of the test animals when using the Draize Test or the Buehler Test or in greater than 30% of the test animals when using one of the five other tests, in which an adjuvant is incorporated, that are specified in the OECD Test No. 406 that is referred to in that section;

  • (d) gene mutation or chromosomal aberration when tested for mutagenicity in accordance with section 5 of Schedule 2; or

  • (e) tumors when tested for tumorigenicity in accordance with section 6 of Schedule 2.

Labelling

Marginal note:Loose-fitting sleepwear

4 Loose-fitting sleepwear that is treated with a flame retardant must have a label that is permanently affixed to it that displays in a clear and legible manner

• (a) the words “flame retardant” and “ignifugeant”; and

• (b) instructions in English and in French for the care of the sleepwear, particularly cleaning procedures, to ensure that it is not exposed to agents or treatments that could reduce its flame resistance.

Repeal

5 [Repeal]

Coming into Force

Marginal note:Registration

6 These Regulations come into force on the day on which they are registered.